日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Outcome of Percutaneous and Surgical Management for Tricuspid Infective Endocarditis: Insights From a National Study

经皮和外科治疗三尖瓣感染性心内膜炎的疗效：一项全国性研究的启示

期刊:CJC Open
影响因子:1.9
doi:10.1016/j.cjco.2024.05.010
Museedi, Abdulrahman S; Alshami, Abbas; Upadhrasta, Sireesha; Urina-Jassir, Daniela; Alsaad, Ali; Rozenbaum, Zach
炎症/感染
发表日期：2024
文献求助 收藏

Early Mechanical Circulatory Support for Cardiogenic Shock

早期机械循环支持治疗心源性休克

期刊:Cardiology in Review
影响因子:2.3
doi:10.1097/CRD.0000000000000485
Upadhrasta, Sireesha; Museedi, Abdulrahman; Thannoun, Tariq; Chaanine, Antoine H; Le Jemtel, Thierry H
发表日期：2023
文献求助 收藏

Effect of Progression of Valvular Calcification on Left Ventricular Structure and Frequency of Incident Heart Failure (from the Multiethnic Study of Atherosclerosis)

瓣膜钙化进展对左心室结构和新发心力衰竭发生率的影响（来自多民族动脉粥样硬化研究）

期刊:American Journal of Cardiology
影响因子:2.1
doi:10.1016/j.amjcard.2020.08.017
Fashanu, Oluwaseun E; Upadhrasta, Sireesha; Zhao, Di; Budoff, Matthew J; Pandey, Ambarish; Lima, Joao A C; Michos, Erin D
心力衰竭
心血管
动脉粥样硬化
发表日期：2020
文献求助 收藏

Effects of Febuxostat on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

非布司他治疗对死亡率和心血管结局的影响：随机对照试验的系统评价和荟萃分析

期刊:Mayo Clinic Proceedings Innovations Quality Outcomes
影响因子:
doi:10.1016/j.mayocpiqo.2020.04.012
Al-Abdouh, Ahmad; Khan, Safi U; Barbarawi, Mahmoud; Upadhrasta, Sireesha; Munira, Srajum; Bizanti, Anas; Elias, Hadi; Jat, Asadulla; Zhao, Di; Michos, Erin D
发表日期：2020
文献求助 收藏

Managing cardiotoxicity associated with immune checkpoint inhibitors

免疫检查点抑制剂相关心脏毒性的管理

期刊:
影响因子:
doi:10.1016/j.cdtm.2019.02.004
Upadhrasta, Sireesha; Elias, Hadi; Patel, Keval; Zheng, Lei
毒理研究
免疫/内分泌
发表日期：2019
文献求助 收藏